Colgate-Palmolive Company Profile Avatar - Palmy Investing

Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers too…
Household & Personal Products
US, New York [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
58.77 59.14 57.31 58.13 58.56 58.51 58.62 60.04 60.05 59.39 59.42 60.82 59.55 57.04 57.82
Profit Margin
14.95 14.15 14.53 14.47 12.86 12.62 8.63 16.06 13.10 15.44 15.08 16.36 12.43 9.93 11.82
Operating Margin
23.59 24.35 22.95 22.76 20.41 20.59 17.39 25.25 23.22 23.76 22.65 23.59 25.68 24.13 21.23
EPS Growth
18.85 -1.76 11.66 4.42 -7.31 -1.25 -35.71 79.09 -16.06 20.00 - - 14.13 -18.73 -16.80 30.52
Return on Assets (ROA)
20.58 19.72 19.11 18.46 16.15 16.20 11.57 20.14 15.97 19.74 15.74 16.93 14.40 11.35 14.03
Return on Equity (ROE)
73.52 82.36 102.36 112.93 97.22 190.39 -462.88 -1,004.53 -3,373.33 -2,352.94 2,023.08 362.72 355.67 445.14 377.67
Return on Invested Capital (ROIC)
26.86 28.67 22.29 34.20 27.10 30.20 23.77 42.20 34.28 43.46 17.23 34.83 42.13 34.47 32.31
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
53.92 55.85 72.62 41.32 47.31 49.42 57.48 53.89 51.97 52.45 104.24 50.28 49.42 56.57 52.73
Debt/Equity
192.65 233.23 389.05 252.81 284.82 580.96 -2,298.66 -2,688.48 -10,980.00 -6,252.94 13,394.02 1,077.39 1,220.53 2,219.20 1,419.38
Debt/EBITDA
65.10 70.43 92.26 100.74 117.52 126.51 103.61 119.82 124.07 134.13 170.98 151.74 127.50 166.48 172.37
Debt/Capitalization
65.83 69.99 79.55 71.66 74.01 85.31 104.55 103.86 100.92 101.63 99.26 91.51 92.43 95.69 93.42
Interest Debt per Share USD
6.09 6.46 9.52 5.90 7.18 7.41 7.77 7.49 7.64 7.55 18.46 9.56 9.02 10.84 10.81
Debt Growth
-15.90 7.61 40.48 8.73 8.16 8.68 6.88 -0.58 0.67 -3.21 23.26 -3.14 -4.68 22.83 1.85
Liquidity
Current Ratio
59.35 57.01 54.04 132.75 135.37 141.28 135.64 131.26 136.56 113.94 36.75 104.86 109.93 128.50 111.35
Quick Ratio
34.67 32.10 31.34 77.74 77.79 82.54 76.05 84.63 89.17 64.16 20.63 52.91 54.07 61.67 57.60
Cash Ratio
9.35 7.49 10.78 25.76 27.01 31.64 30.01 39.79 45.19 21.81 7.77 21.46 20.80 19.48 20.38
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
522.66 520.46 538.36 524.03 506.60 518.67 562.29 518.53 505.65 505.04 454.86 385.77 416.43 372.18 424.30
Receivables Turnover
942.62 966.71 999.05 1,024.28 1,064.79 1,113.21 1,123.62 1,076.90 1,044.19 1,110.29 1,089.79 1,303.09 1,343.18 1,194.61 1,226.80
Payables Turnover
539.16 545.92 574.28 554.50 537.53 582.29 597.75 540.21 509.41 516.61 514.79 463.32 476.40 497.68 483.27
Asset Turnover
137.66 139.31 131.52 127.56 125.54 128.37 134.09 125.34 121.92 127.82 104.38 103.46 115.83 114.21 118.69
Coverage
Interest Coverage
4,694.81 6,423.73 6,510.17 4,861.25 3,065.52 2,736.15 2,096.99 2,575.17 2,345.75 1,913.99 1,851.04 2,122.95 2,330.21 2,595.81 1,381.61
Asset Coverage
200 200 100 100 100 100 100 100 - - 100 100 100 100 100 100
Cash Flow Coverage (CFGR)
54.59 51.47 31.34 57.75 48.80 49.58 42.91 48.08 46.36 47.91 19.99 46.46 44.73 28.72 43.32
EBITDA Coverage
5,100 7,000 7,200 5,300 3,400 3,000 4,000 2,900 2,600 2,100 2,100 2,400 2,600 2,900 1,500
Dividend Coverage
-200 -100 -200 -100 -100 -100 - - -100 -100 -100 -100 -100 -100 -100 -100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
2.39 2.91 2.67 2.57 2.28 2.28 2.48 2.58 2.30 3.07 2.73 2.26 2.33 2.57 2.65
Earnings Yield
5.58 5.62 5.39 4.97 3.69 3.44 2.30 4.18 3.04 4.63 4.00 3.68 3.00 2.71 3.49
Price/Earnings (P/E)
1,790.87 1,779.82 1,855.98 2,013.41 2,708.50 2,904.39 4,342.82 2,390.80 3,287.14 2,159.09 2,498.54 2,718.55 3,329.28 3,691.87 2,867.48
Price/Book (P/B)
1,316.72 1,465.77 1,899.74 2,273.71 2,633.30 5,529.76 -20,101.86 -24,016.21 -110,886.35 -50,802.07 50,547.39 9,860.70 11,841.10 16,433.90 10,829.57
Price/Sales (P/S)
267.69 251.92 269.62 291.32 348.44 366.47 374.86 384.07 430.52 333.36 376.86 444.81 413.94 366.78 338.96
Price/Cash Flow (P/CF)
1,252.03 1,221.10 1,557.97 1,557.31 1,894.43 1,919.82 2,038.13 1,857.99 2,178.51 1,695.62 1,887.66 1,970.02 2,168.79 2,578.25 1,761.07
End of CL's Analysis
CIK: 21665 CUSIP: 194162103 ISIN: US1941621039 LEI: - UEI: -
Secondary Listings